since 1980, medifast, inc.(nyse: med) has been a brand recommended by 20,000 doctors. developed by a physician, medifast is a clinically proven nutrition and weight loss company based in maryland. we change lives by producing results and helping those succeed. because everyone has different goals and ways of learning, we offer several support programs as you choose health with medifast. we believe that healthier people are happier people. everyone has the right to feel good about themselves. our vision is to create a world where it's easy to take control of your own well-being. we're on a mission to empower people with the right opportunities to enjoy the healthy life they deserve. we see it every day. the ear-to-ear grin. the “holding back the tears” pride. the glow of pure joy when someone reaches their weight-loss goals. their whole life gets better, and so does yours, because you helped them get there. if you’d like to spend every day helping to change people’s lives for the better
Company profile
Ticker
MED
Exchange
Website
CEO
Daniel Chard
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
HEALTHRITE INC
SEC CIK
Corporate docs
Subsidiaries
Corporate Events, Inc. • Jason Enterprises, Inc. • Jason Pharmaceuticals, Inc. • Jason Properties, LLC • OPTAVIA LLC • OPTAVIA Health Consultation (Shanghai) Co., Ltd. • OPTAVIA (Hong Kong) Limited • OPTAVIA (Singapore) PTE. LTD • Seven Crondall Associates, LLC ...
IRS number
133714405
MED stock data
Latest filings (excl ownership)
10-Q
2024 Q2
Quarterly report
5 Aug 24
8-K
Medifast Announces Second Quarter 2024 Financial Results
5 Aug 24
8-K
Departure of Directors or Certain Officers
21 Jun 24
ARS
2023 FY
Annual report to shareholders
8 May 24
10-Q
2024 Q1
Quarterly report
29 Apr 24
8-K
Medifast Announces First Quarter 2024 Financial Results
29 Apr 24
DEFA14A
Additional proxy soliciting materials
26 Apr 24
DEF 14A
Definitive proxy
26 Apr 24
8-K
Medifast Announces Fourth Quarter and Full Year 2023 Financial Results
20 Feb 24
10-K
2023 FY
Annual report
20 Feb 24
Transcripts
MED
Earnings call transcript
2023 Q4
20 Feb 24
MED
Earnings call transcript
2023 Q3
6 Nov 23
MED
Earnings call transcript
2023 Q2
7 Aug 23
MED
Earnings call transcript
2023 Q2
7 Aug 23
MED
Earnings call transcript
2023 Q1
1 May 23
MED
Earnings call transcript
2022 Q4
21 Feb 23
MED
Earnings call transcript
2022 Q3
4 Nov 22
MED
Earnings call transcript
2022 Q2
4 Aug 22
MED
Earnings call transcript
2022 Q1
3 May 22
MED
Earnings call transcript
2021 Q4
24 Feb 22
Latest ownership filings
4
Jonathan Barrett MacKenzie
17 Sep 24
SC 13G/A
VANGUARD GROUP INC
10 Jul 24
SC 13G/A
BlackRock Inc.
8 Jul 24
SC 13G
MILLENNIUM MANAGEMENT LLC
1 Jul 24
4
JEFFREY J BROWN
24 Jun 24
4
Andrea B Thomas
24 Jun 24
4
Elizabeth A. Geary
24 Jun 24
4
Michael A. Hoer
24 Jun 24
4
SCOTT SCHLACKMAN
24 Jun 24
4
Ming Xian
24 Jun 24
Financial summary
Quarter (USD) | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 108.02 mm | 108.02 mm | 108.02 mm | 108.02 mm | 108.02 mm | 108.02 mm |
Cash burn (monthly) | (no burn) | 3.28 mm | 3.55 mm | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | n/a | 12.33 mm | 13.33 mm | n/a | n/a | n/a |
Cash remaining | n/a | 95.69 mm | 94.69 mm | n/a | n/a | n/a |
Runway (months of cash) | n/a | 29.2 | 26.7 | n/a | n/a | n/a |
Institutional ownership, Q2 2024
95.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 157 |
Opened positions | 40 |
Closed positions | 67 |
Increased positions | 49 |
Reduced positions | 46 |
13F shares | Current |
---|---|
Total value | 206.27 bn |
Total shares | 10.40 mm |
Total puts | 494.80 k |
Total calls | 553.80 k |
Total put/call ratio | 0.9 |
Largest owners | Shares | Value |
---|---|---|
Renaissance Technologies | 958.61 k | $20.92 bn |
BLK BlackRock | 829.21 k | $18.09 bn |
Vanguard | 723.31 k | $15.78 bn |
Millennium Management | 469.22 k | $10.24 bn |
Aqr Capital Management | 389.95 k | $8.51 bn |
Acadian Asset Management | 338.23 k | $7.38 mm |
D. E. Shaw & Co. | 337.81 k | $7.37 bn |
MS Morgan Stanley | 336.76 k | $7.35 bn |
Arrowstreet Capital, Limited Partnership | 332.31 k | $7.25 mm |
Hotchkis & Wiley Capital Management | 322.88 k | $7.05 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Sep 24 | Jonathan Barrett MacKenzie | Common Stock | Payment of exercise | Dispose F | No | No | 18.9 | 11 | 207.90 | 3,906 |
20 Jun 24 | Schlackman Scott | Common Stock | Grant | Acquire A | No | No | 0 | 6,596 | 0.00 | 14,380.707 |
20 Jun 24 | Xian Ming | RSU Common Stock | Grant | Acquire A | No | No | 0 | 10,149 | 0.00 | 14,961.918 |
20 Jun 24 | Hoer Michael A. | Common Stock | Grant | Acquire A | No | No | 0 | 6,596 | 0.00 | 14,971.473 |
20 Jun 24 | Thomas Andrea B | Common Stock | Grant | Acquire A | No | No | 0 | 6,596 | 0.00 | 12,849.123 |